SIM1 and Alzheimer disease: Using CRISPRa systems targeting both the promoter and enhancer of SIM1 in an AD mouse model of obesity, Matharu et al. observed efficient and specific upregulation of SIM1 mRNA levels as well as a statistically significant reduction in mouse weight (71).